{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T04:28:20Z","timestamp":1790742500795,"version":"4.1.0"},"reference-count":21,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Infectious Diseases Now"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.idnow.2021.01.009","type":"journal-article","created":{"date-parts":[[2021,1,22]],"date-time":"2021-01-22T12:19:14Z","timestamp":1611317954000},"page":"362-367","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Daptomycin versus teicoplanin in the treatment of osteomyelitis: Results of the G\u00f6ztepe retrospective cohort study"],"prefix":"10.1016","volume":"51","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1243-2746","authenticated-orcid":false,"given":"O.R.","family":"Sipahi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.A.","family":"Erdem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Kahraman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Kur\u015fun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.M.","family":"Suntur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Demirdal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.A.","family":"Nemli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4120-0781","authenticated-orcid":false,"given":"M.","family":"Dizbay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Ulug","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"\u00d6ztoprak-Cuvalci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Arda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Quliyeva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Tasbakan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Uysal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Sipahi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Aydemir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Ulusoy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1A Suppl.","key":"10.1016\/j.idnow.2021.01.009_bib0110","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0002-9610(03)00292-7","article-title":"Surgical management of chronic osteomyelitis","volume":"188","author":"Parsons","year":"2004","journal-title":"Am J Surg"},{"key":"10.1016\/j.idnow.2021.01.009_bib0115","first-page":"15","article-title":"New antibiotics in the therapy of osteomyelitis","volume":"6","author":"Hirsiger","year":"2017","journal-title":"Mediterr J Infect Microb Antimicrob"},{"issue":"3","key":"10.1016\/j.idnow.2021.01.009_bib0120","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1093\/cid\/ciq146","article-title":"Clinical practice guidelines by Infectious Diseases Society of America (IDSA) for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children","volume":"52","author":"Liu","year":"2011","journal-title":"Clin Infect Dis"},{"issue":"6","key":"10.1016\/j.idnow.2021.01.009_bib0125","doi-asserted-by":"crossref","first-page":"e26","DOI":"10.1093\/cid\/civ482","article-title":"Clinical Practice Guidelines by Infectious Diseases Society of America (IDSA) for the Diagnosis and Treatment of Native Vertebral Osteomyelitis in Adults","volume":"61","author":"Berbari","year":"2015","journal-title":"Clin Infect Dis"},{"issue":"Suppl. A","key":"10.1016\/j.idnow.2021.01.009_bib0130","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1093\/jac\/21.suppl_A.81","article-title":"Teicoplanin compared with vancomycin in methicillin-resistant Staphylococcus aureus infections: preliminary results","volume":"21","author":"Van Laethem","year":"1988","journal-title":"J Antimicrob Chemother"},{"issue":"8","key":"10.1016\/j.idnow.2021.01.009_bib0135","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1097\/00007611-199308000-00009","article-title":"Safety and efficacy of teicoplanin for bone and joint infections: results of a community-based trial","volume":"86","author":"Weinberg","year":"1993","journal-title":"South Med J"},{"issue":"6","key":"10.1016\/j.idnow.2021.01.009_bib0140","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/j.clinthera.2013.05.008","article-title":"A stewardship program's retrospective evaluation of vancomycin AUC24\/MIC and time to microbiological clearance in patients with methicillin-resistant Staphylococcus aureus bacteremia and osteomyelitis","volume":"35","author":"Gawronski","year":"2013","journal-title":"Clin Ther"},{"issue":"5","key":"10.1016\/j.idnow.2021.01.009_bib0145","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1179\/joc.2000.12.5.412","article-title":"Long-term intramuscular teicoplanin treatment of chronic osteomyelitis due to oxacillin-resistant Staphylococcus aureus in outpatients","volume":"12","author":"Testore","year":"2000","journal-title":"J Chemother"},{"issue":"567","key":"10.1016\/j.idnow.2021.01.009_bib0150","first-page":"9","article-title":"Teicoplanin in the treatment of bone and joint infections. Teicoplanin Bone and Joint Cooperative Study Group, USA","author":"LeFrock","year":"1992","journal-title":"Eur J Surg Suppl"},{"issue":"11","key":"10.1016\/j.idnow.2021.01.009_bib0155","doi-asserted-by":"crossref","first-page":"5626","DOI":"10.1128\/AAC.00038-12","article-title":"Randomized controlled trial of the safety and efficacy of Daptomycin versus standard-of-care therapy for management of patients with osteomyelitis associated with prosthetic devices undergoing two-stage revision arthroplasty","volume":"56","author":"Byren","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"10.1016\/j.idnow.2021.01.009_bib0160","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.ijantimicag.2013.05.005","article-title":"Daptomycin: the role of high-dose and combination therapy for Gram-positive infections","volume":"42","author":"Gould","year":"2013","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.idnow.2021.01.009_bib0165","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/nyas.12948","article-title":"Mechanisms of drug resistance: daptomycin resistance","volume":"1354","author":"Tran","year":"2015","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.idnow.2021.01.009_bib0170","doi-asserted-by":"crossref","first-page":"23","DOI":"10.5578\/mjima.9107","article-title":"Daptomycin experience between years 2009\u20132013: review of 139 cases","volume":"3","author":"Candevir-Ulu","year":"2014","journal-title":"Mediterr J Infect Microb Antimicrob"},{"issue":"1","key":"10.1016\/j.idnow.2021.01.009_bib0175","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1093\/jac\/dkm437","article-title":"Outcomes with daptomycin versus standard therapy for osteoarticular infections associated with Staphylococcus aureus bacteraemia","volume":"61","author":"Lalani","year":"2008","journal-title":"J Antimicrob Chemother"},{"issue":"4","key":"10.1016\/j.idnow.2021.01.009_bib0180","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1007\/s10096-013-2001-y","article-title":"Daptomycin versus vancomycin for osteoarticular infections due to methicillin-resistant Staphylococcus aureus (MRSA): a nested case-control study","volume":"33","author":"Liang","year":"2014","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.idnow.2021.01.009_bib0185","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s12941-016-0130-8","article-title":"Real-world daptomycin use across wide geographical regions: results from a pooled analysis of CORE and EU-CORE","volume":"15","author":"Seaton","year":"2016","journal-title":"Ann Clin Microbiol Antimicrob"},{"issue":"7","key":"10.1016\/j.idnow.2021.01.009_bib0190","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1016\/j.clinthera.2012.06.013","article-title":"Daptomycin compared to vancomycin for the treatment of osteomyelitis: a single-center, retrospective cohort study","volume":"34","author":"Moenster","year":"2012","journal-title":"Clin Ther"},{"key":"10.1016\/j.idnow.2021.01.009_bib0195","series-title":"Performance standards for antimicrobial susceptibility testing: twenty-third informational supplement M100-S23","author":"Clinical and Laboratory Standards Institute","year":"2013"},{"issue":"3","key":"10.1016\/j.idnow.2021.01.009_bib0200","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.bjid.2019.05.006","article-title":"Daptomycin to bone and joint infections and prosthesis joint infections: a systematic review","volume":"23","author":"Telles","year":"2019","journal-title":"Braz J Infect Dis"},{"issue":"7","key":"10.1016\/j.idnow.2021.01.009_bib0205","doi-asserted-by":"crossref","first-page":"3991","DOI":"10.1128\/AAC.02344-14","article-title":"Penetration of daptomycin into bone and synovial fluid in joint replacement","volume":"58","author":"Montange","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"issue":"12","key":"10.1016\/j.idnow.2021.01.009_bib0210","doi-asserted-by":"crossref","first-page":"793","DOI":"10.2165\/0003088-200847120-00004","article-title":"Glycopeptide bone penetration in patients with septic pseudoarthrosis of the tibia","volume":"47","author":"Garazzino","year":"2008","journal-title":"Clin Pharmacokinet"}],"container-title":["Infectious Diseases Now"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666991921000294?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666991921000294?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T07:29:33Z","timestamp":1763018973000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666991921000294"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":21,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["S2666991921000294"],"URL":"https:\/\/doi.org\/10.1016\/j.idnow.2021.01.009","relation":{},"ISSN":["2666-9919"],"issn-type":[{"value":"2666-9919","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Daptomycin versus teicoplanin in the treatment of osteomyelitis: Results of the G\u00f6ztepe retrospective cohort study","name":"articletitle","label":"Article Title"},{"value":"Infectious Diseases Now","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.idnow.2021.01.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}